Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
jefferson.eduTotal trials
161
Active
9
Phase 3
6
Total enrollment
10,932
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Sunitinib | — | — | — | — | 2 | ||
| Valproic Acid | — | — | — | — | — | 1 | |
| Sunitinib Malate | — | — | — | — | — | 1 | |
| Sunitinib Malate + Valproic Acid | — | — | — | — | — | 1 | |
| Ibrutinib | — | — | — | — | — | 1 | |
| Obinutuzumab | — | — | — | — | — | 1 | |
| Linaclotide | — | — | — | — | — | 1 |
Next readouts
- 2026-06-30
- 2026-09-11
- 2026-12-31
Top conditions
- Prostate Cancer11
- Breast Cancer6
- Malignant Neoplasm5
- Head and Neck Cancer5
- Breast Carcinoma5
- Non-Hodgkin's Lymphoma4
- Aplastic Anemia4
- Larynx4
Frequently asked questions about Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- How many clinical trials does Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University have on ClinicalTrials.gov?
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University is listed as the lead sponsor on 161 clinical trials in ClinicalTrials.gov, 9 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University's trials are in Phase 3?
- 6 of Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University focus on?
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University's most-studied conditions on ClinicalTrials.gov are Prostate Cancer, Breast Cancer, Malignant Neoplasm, Head and Neck Cancer, Breast Carcinoma.
- When are Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University's next clinical trial readouts?
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University has 3 upcoming primary-completion readouts tracked here; the soonest is “Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer”, expected around 2026-06-30.